America’s national debt will soon zoom past a staggering $20 trillion, double the amount of debt our nation owed a mere eight years ago. Meanwhile government is collecting record tax revenues on workers and industry, filling the Treasury so fast it’s in peril of bursting at the seams. CASE believes this policy of record borrowing, taxing and spending is both reckless and immoral, choking economic investment and growth that negatively impacts the financial future of every American. Unsustainable debt and taxes are leading our nation to economic ruin, and future generations will be crippled by inheriting mountainous debt. CASE strongly opposes tax increases on America’s consumers and workers, and will vigorously promote budget plans that reign in government spending and provide Americans with lasting tax relief.
Search
Categories
- Aegis
- Agriculture
- Commerce
- Communications
- Consumer Safety
- Data Privacy
- Economy
- Education
- Energy
- Entertainment
- Environment
- Financial Services
- Fiscal Policy
- Healthcare
- Higher Ed on the Hill
- Intellectual Property
- Kentucky
- Labor
- Legal
- Lifestyle
- Manufacturing
- Media
- Regulation
- Retail
- Robotexts
- Taxes
- TCPA
- Technology
- Trade
- Transportation
- Uncategorized
- Veterans
Archives
Contact Us
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/